,,ii #aadth ,,congress #ast ,session ,s4 #acib ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,may #bj1 #bjae ,mr4 ,markey introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to require certain practitioners authorized to prescribe controlled substances to complete continuing education4 #a4 ,short title ,this ,act may be cited as the ,safer ,prescribing of ,controlled ,substances ,act4 #b4 ,continuing education requirements for certain practitioners prescribing controlled substances ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended-- 7#a7 in subsection 7f71 in the matter preceding paragraph 7#a71 by striking ,the ,attorney ,general shall register and inserting ,subject to subsection 7i71 the ,attorney ,general shall register2 and 7#b7 by adding at the end the following3 7i7 7#a7 ,in this subsection1 the term covered practitioner means a practitioner that is not a hospital1 pharmacy1 or veterinarian4 7#b7 ,as a condition of granting or renewing the registration of a covered practitioner under this part to dispense1 or conduct research with1 controlled substances in schedule ,,ii1 ,,iii1 ,,iv1 or ,v1 the ,attorney ,general shall require the covered practitioner to complete training 7through classroom situations1 seminars at professional society meetings1 electronic communications1 or otherwise7 that the ,secretary of ,health and ,human ,services determines meets the requirements under paragraph 7#c74 7#c7 ,the training provided for purposes of paragraph 7#b7 shall1 at a minimum1 expose covered practitioners to-- 7,a7 best practices for pain management1 including alternatives to prescribing controlled substances and other alternative therapies to decrease the use of opioids2 7,b7 responsible prescribing of pain medications1 as described in ,federal prescriber guidelines for nonmalignant pain2 7,c7 methods for diagnosing1 treating1 and managing a substance use disorder1 including the use of medications approved by the ,food and ,drug ,administration and evidence-based nonpharmacological therapies2 7,d7 linking patients to evidence-based treatment for substance use disorders2 and 7,e7 tools to manage adherence and diversion of controlled substances1 including prescription drug monitoring programs1 drug screening1 informed consent1 overdose education1 and the use of opioid overdose antagonists4 7#d7 ,the ,substance ,abuse and ,mental ,health ,services ,administration shall establish or support the establishment of not less than #a training module that meets the requirements under paragraph 7#c7 that is provided-- 7,a7 to any covered practitioner registered or applying for a registration under this part to dispense1 or conduct research with1 controlled substances in schedule ,,ii1 ,,iii1 ,,iv1 or ,v2 7,b7 online2 and 7,c7 free of charge4 7#e7 ,the ,secretary of ,health and ,human ,services shall establish1 maintain1 and periodically update a publically available database providing information relating to training modules that meet the requirements under paragraph 7#c74 7#f7 ,not later than #e years after the date of enactment of this subsection1 the ,secretary of ,health and ,human ,services shall evaluate and make publically available a report describing how exposure to the training required under this subsection has changed prescribing patterns of controlled substances4 4